Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 700 shares at $83.46 ($58K) on 2017-04-03, disclosed to the SEC on 2017-04-04.
Open-market sale of $58k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-07-11 | $906K | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |